HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease
European Journal of Neurology · 2026-05 · 33 (5)
DOI: 10.1111/ene.70619 ↗At a glance
Journal article in European Journal of Neurology, published online on 2026-05-11. Written by Lin Bai and 11 co-authors. Institution: Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. Major MEDLINE topics: Autoantibodies, Autoimmune Diseases of the Nervous System, Genetic Predisposition to Disease, Glutamate Decarboxylase. 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National High Level Hospital Clinical Research Funding, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (original language)
Object Glutamic acid decarboxylase antibody‐associated neurological disease (GADAND) is a rare autoimmune disorder with elusive immunogenetic underpinnings. We aimed to investigate HLA associations with GADAND susceptibility in a Chinese cohort.
Methods
We performed HLA genotyping at the HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1, and ‐DQB1 loci in 62 Chinese patients with GADAND and compared them with 990 healthy controls. Haplotype frequencies were estimated using the expectation–maximization (EM) algorithm. Allele and haplotype associations with disease susceptibility and clinical phenotypes were assessed.
Results
We identified the HLA class I haplotype A*11:01 ~ B*40:01 ~ C*07:02 as a susceptibility haplotype for GADAND (OR = 10.22, 95% CI 3.86–25.57, p adj = 0.003), and the association was stronger for the extended haplotype including DQA1*01:03 (OR = 25.61, 95% CI 4.99–89.11, p adj < 0.001). Three haplotypes showed suggestive but non‐significant associations: B*44:02 ~ C*05:01 (OR = 8.32, 95% CI 2.52–24.48, p adj = 0.069), DQA1*01:03 ~ DQB1*06:01 ~ DRB1*08:03 (OR = 3.15, 95% CI 1.67–5.63, p adj = 0.066), and DQA1*05:05 ~ DQB1*03:01, which showed a suggestive protective effect (OR = 0.15, 95% CI 0.018–0.556, p adj = 0.088). T1DM risk haplotypes, including DQA1*03:01 ~ DQB1*03:02 ~ DRB1*04:03 (OR = 5.04, 95% CI 1.18–16.62, p adj = 0.744) and DQA1*05:01 ~ DQB1*02:01 ~ DRB1*03:01 (OR = 2.50, 95% CI 1.07–5.24, p adj = 0.829), were more frequent in GADAND patients, and A*11:01 ~ B*40:01 ~ C*07:02 was enriched in those with comorbid AITD. No statistically significant associations were identified between HLA haplotypes and clinical phenotypes.
Conclusions
The haplotype A*11:01 ~ B*40:01 ~ C*07:02 was associated with GADAND susceptibility in the Chinese population, implicating T cell involvement. T1DM‐associated haplotypes were overrepresented in GADAND, and A*11:01 ~ B*40:01 ~ C*07:02 was enriched in comorbid AITD, suggesting HLA as a shared immunogenetic basis for autoimmune comorbidities. No significant HLA associations with clinical phenotypes were identified, warranting validation in larger cohorts.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
- Department of Molecular Biology and Biochemistry, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine…
- Center for Bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colleg…
ORCID profiles: Lin Bai, Siyuan Fan, Hongzhi Guan, Meng Xiao
Funding
- National High Level Hospital Clinical Research Funding
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Cite
APA
Bai, L., Ren, H., Lu, Q., Zhang, H., Yu, Y., Yang, Z., Yang, X., Fan, S., Wan, X., Zhu, Y., Guan, H., & Xiao, M. (2026). HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease. European Journal of Neurology, 33(5). https://doi.org/10.1111/ene.70619
Vancouver
Bai L, Ren H, Lu Q, Zhang H, Yu Y, Yang Z, et al. HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease. European Journal of Neurology. 2026;33(5). doi:10.1111/ene.70619
BibTeX
@article{Bai2026,
author = {Bai, Lin and Ren, Haitao and Lu, Qiang and Zhang, Han and Yu, Yang and Yang, Zhuo and Yang, Xinzhuang and Fan, Siyuan and Wan, Xinhua and Zhu, Yicheng and Guan, Hongzhi and Xiao, Meng},
title = {HLA Class I Haplotype in Glutamic Acid Decarboxylase Antibody‐Associated Neurological Disease},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {5},
doi = {10.1111/ene.70619}
}
EUVIMED